tirzepatide vs semaglutide mechanism
Your GLP-1 Option Is Wrong Exposing Semaglutide's Achilles Heel
Semaglutide is not the optimal GLP-1 choice for many patients because its single-target action leaves a metabolic ceiling that dual-agonists like tirzepatide can surpass. In 2023, it accounted for over 3 million prescriptions, ranking 157th in the United States. Medical Disclaimer: This article is for informational purposes only and does